Updated Date:
27 May 2025
Product Detail:
SAXENDA liraglutide (rys) 6mg/mL solution for injection pre-filled pen
Shortage Status:
Discontinued
AUST R:
225804
Availability:
Reduction in supply until supply is exhausted
Active Ingredient:
Liraglutide
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Injection,solution
Supply Impact Dates
Management Action:
Patients are advised to consult their healthcare professionals to discuss alternative treatment options.
